The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Mouse models of sarcopenia: classification and evaluation
Open accessAbstract
Sarcopenia is a progressive and widespread skeletal muscle disease that is related to an increased possibility of adverse consequences such as falls, fractures, physical disabilities and death, and its risk increases with age. With the deepening of the understanding of sarcopenia, the disease has become a major clinical disease of the elderly and a key challenge of healthy ageing. However, the exact molecular mechanism of this disease is still unclear, and the selection of treatment strategies and the evaluation of its effect are not the same. Most importantly, the early symptoms of this disease are not obvious and are easy to ignore. In addition, the clinical manifestations of each patient are not exactly the same, which makes it difficult to effectively study the progression of sarcopenia. Therefore, it is necessary to develop and use animal models to understand the pathophysiology of sarcopenia and develop therapeutic strategies. This paper reviews the mouse models that can be used in the study of sarcopenia, including ageing models, genetically engineered models, hindlimb suspension models, chemical induction models, denervation models, and immobilization models; analyses their advantages and disadvantages and application scope; and finally summarizes the evaluation of sarcopenia in mouse models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 1×
“In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) first proposed the widely used comprehensive diagnostic criteria for sarcopenia and recommended that muscle quality, muscle strength, and muscle function should be evaluated simultaneously in the diagnosis of sarcopenia.(2) In 2018, the EWGSOP2…”
BackgroundAsian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fiber Types in Mammalian Skeletal Muscles
Schiaffino, S., & Reggiani, C. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2010 · Cited by 3,022 · cited 1×
“However, mouse muscle is mainly composed of Type II (fast muscle) fibres.(36) Moreover, the composition of human skeletal muscle fibres is different from that of mice.”
BackgroundPremature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“The term ‘sarcopenia’ was first proposed by the Rosenberg team to describe the decrease in skeletal muscle mass with age.(1) In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) first proposed the widely used comprehensive diagnostic criteria for sarcopenia and recommended that muscle quality, mu…”
BackgroundLauretani, F., Russo, C. R., Bandinelli, S., Bartali, B., Cavazzini, C., Di Iorio, A., Corsi, A. M., Rantanen, T., Guralnik, J. M., & Ferrucci, L. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00246.2003 · Cited by 1,946
Human aging, muscle mass, and fiber type composition.
Evans, W. J., & Lexell, J. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.11 · Cited by 1,308
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
d-Galactose-induced accelerated aging model: an overview
Azman, K. F., & Zakaria, R. (2019) · Biogerontology · doi:10.1007/s10522-019-09837-y · Cited by 553
Fry, C. S., Lee, J. D., Mula, J., Kirby, T. J., Jackson, J. R., Liu, F., Yang, L., Mendias, C. L., Dupont-Versteegden, E. E., McCarthy, J. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3710 · Cited by 432
Bischoff-Ferrari, H. A., Orav, J. E., Kanis, J. A., Rizzoli, R., Schlögl, M., Staehelin, H. B., Willett, W. C., & Dawson-Hughes, B. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3194-y · Cited by 332
Animal models of aging research: implications for human aging and age-related diseases
Mitchell, S. J., Scheibye-Knudsen, M., Longo, D. L., & de Cabo, R. (2015) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022114-110829 · Cited by 328
Using the mouse to model human disease: increasing validity and reproducibility
Justice, M. J., & Dhillon, P. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024547 · Cited by 281
The health economics burden of sarcopenia: a systematic review
Bruyère, O., Beaudart, C., Ethgen, O., Reginster, J.-Y., & Locquet, M. (2019) · Maturitas · doi:10.1016/j.maturitas.2018.11.003 · Cited by 275 · cited 1×
“with sarcopenia were found to have higher medical costs, despite some confounding factors.(15) Sarcopenia increases the”
BackgroundMitochondrial morphology is altered in atrophied skeletal muscle of aged mice
Leduc-Gaudet, J.-P., Picard, M., Pelletier, F. S.-J., Sgarioto, N., Auger, M.-J., Vallée, J., Robitaille, R., St-Pierre, D. H., & Gouspillou, G. (2015) · Oncotarget · doi:10.18632/oncotarget.4235 · Cited by 273
Camporez, J.-P. G., Petersen, M. C., Abudukadier, A., Moreira, G. V., Jurczak, M. J., Friedman, G., Haqq, C. M., Petersen, K. F., & Shulman, G. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525795113 · Cited by 184
Huang, D.-D., Fan, S.-D., Chen, X.-Y., Yan, X.-L., Zhang, X.-Z., Ma, B.-W., Yu, D.-Y., Xiao, W.-Y., Zhuang, C.-L., & Yu, Z. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.01.022 · Cited by 162
Self-citationJoseph, A.-M., Adhihetty, P. J., Wawrzyniak, N. R., Wohlgemuth, S. E., Picca, A., Kujoth, G. C., Prolla, T. A., & Leeuwenburgh, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069327 · Cited by 161 · cited 1×
“loss), kyphosis (curvature of the spin), osteoporosis, and sarcopenia.(90,91) This evidence suggests that the POLG mouse”
BackgroundMuscle wasting and aging: Experimental models, fatty infiltrations, and prevention
Brioche, T., Pagano, A. F., Py, G., & Chopard, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.006 · Cited by 129
Chen, L.-H., Huang, S.-Y., Huang, K.-C., Hsu, C.-C., Yang, K.-C., Li, L.-A., Chan, C.-H., & Huang, H.-Y. (2019) · Aging · doi:10.18632/aging.101782 · Cited by 117
High Intensity Interval Training Improves Physical Performance and Frailty in Aged Mice
Seldeen, K. L., Lasky, G., Leiker, M. M., Pang, M., Personius, K. E., & Troen, B. R. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx120 · Cited by 104 · cited 1×
“Of course, there are also natural ageing mouse models of other ages, such as 27 months old,(42) 88–96 weeks old,(43) 22 months old,(44,45) and 24 months old.(46) For sex selection,”
BackgroundEnergy Metabolism and Ageing in the Mouse: A Mini-Review
Azzu, V., & Valencak, T. G. (2017) · Gerontology · doi:10.1159/000454924 · Cited by 90 · cited 1×
“and tissue and system biology between aged mice and aged humans.(23) At the biochemical and histological levels, biopsies”
BackgroundInoue, A., Cheng, X. W., Huang, Z., Hu, L., Kikuchi, R., Jiang, H., Piao, L., Sasaki, T., Itakura, K., Wu, H., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12166 · Cited by 89
‘Accelerated aging’: a primrose path to insight?
Miller, R. A. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00081.x · Cited by 87 · cited 1×
“of the lens, liver, thymus, skin, and muscle of adult mice can hardly be distinguished from those of adult humans.(24) Humans and mice are also highly similar at the gene level.”
BackgroundSarcopenic obesity: research advances in pathogenesis and diagnostic criteria
Xie, W.-Q., Xiao, G.-L., Fan, Y.-B., He, M., Lv, S., & Li, Y.-S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01435-9 · Cited by 86
Self-citationKim, C., & Hwang, J.-K. (2020) · Nutrients · doi:10.3390/nu12041079 · Cited by 80 · cited 1×
“Subsequently, they used 18-month-old C57BL/6J mice to determine the inhibitory effect of 5,7-dimethoxyflavone (DMF) on sarcopenia, suggesting that DMF may have a potential role in the development of sarcopenia.(39) More studies have been conducted on mice with sarcopenia after 18 months of age.”
MethodKob, R., Fellner, C., Bertsch, T., Wittmann, A., Mishura, D., Sieber, C. C., Fischer, B. E., Stroszczynski, C., & Bollheimer, C. L. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12019 · Cited by 48 · cited 1×
“older animals fed a high-fat diet can be used to study sarcopenia is that fat consumption has been proven to be a constant risk factor for the development of obesity and age-related muscle consumption.(52) Lee et al.”
BackgroundAn embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse
Traoré, M., Gentil, C., Benedetto, C., Hogrel, J.-Y., De la Grange, P., Cadot, B., Benkhelifa-Ziyyat, S., Julien, L., Lemaitre, M., Ferry, A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1131 · Cited by 36
Zhou, H., Yuan, D., Gao, W., Tian, J., Sun, H., Yu, S., Wang, J., & Sun, L. (2020) · IUBMB Life · doi:10.1002/iub.2289 · Cited by 22
Cited by
The effects of myosteatosis on skeletal muscle function in older adults
Dondero, K., Friedman, B., Rekant, J., Landers‐Ramos, R., & Addison, O. (2024) · Physiological Reports · doi:10.14814/phy2.16042 · Cited by 63
Cheng, K. Y.-K., Bao, Z., Long, Y., Liu, C., Huang, T., Cui, C., Chow, S. K.-H., Wong, R. M. Y., & Cheung, W.-H. (2023) · Subcellular Biochemistry · doi:10.1007/978-3-031-26576-1_6 · Cited by 14
Jonk, S. M., Nicol, A., Chrysostomou, V., Lardner, E., Yu, S.-C., Stålhammar, G., Crowston, J. G., Tribble, J. R., Swoboda, P., & Williams, P. A. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103732 · Cited by 6
Metadata
- Authors
- Xie, W., He, M., Yu, D., Wu, Y., Wang, X., Lv, S., Xiao, W., & Li, Y.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2021-05-05
- Volume
- 12
- Issue
- 3
- Pages
- 538-554
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W3158552092
- Cited by
- 231
- References
- 31
- FWCI
- 17.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.